DiabetOmics: DiabetOmics to invest $5 mn in medical diagnostics in India
DiabetOmics, a US based medical diagnostic major, is planning to invest $5 million in the next 4 years to commercialize its non invasive patented technology for diagnosis of diabetics in the country.
Read full article »
President & CEO
Srinivasa Nagalla
DiabetOmics engages in the non-invasive assessment and management of personalized health, diabetes risk, progression and complications.
Read more